While the mean weight change after discontinuation was small in both groups, individual outcomes varied considerably
Its broader point is that a plateau usually reflects overlapping metabolic and behavioral factors rather than a defective medication
Regular check-ins ensure that both the benefits and potential risks are effectively managed
Clinical trials of Tirzepatide, including studies that also refer to the brand Zepbound, have shown up to about 22 percent average weight reduction at higher doses over 72 weeks for some participants with obesity or excess weight
It is chemically a true peptide (six amino acids, including two D-amino acid substitutions for stability), so unlike some non-peptide GH secretagogues it is correctly classified in this category
Epigenetic and environmental changes are various in different countries, and this issue may lead to different responses to NAC supplementation (Reference Diamanti-Kandarakis, Kandarakis and Legro33)